Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
1.7%
1w
0.2%
1m
17.4%
3m
19.6%
6m
23.8%
1y
8.2%
all
25.3%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep22Jun23Mar24Dec24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

708 1.7%
673
946
Company Overview

Sales
1,906 Cr
Growth: -4.3%
Profit after Tax
240 Cr
Growth: -10.0%
Small Cap
6,422 Cr
P/E: 26.8x
Industry P/E: 33.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,906
Growth -4.3%
EBITDA 23.3%
P/S 3.4x
Dividend 0.5%
P/E 26.8x
Book Value ₹ 228
PEG Ratio -6.0x
ROE 11.9%
P/B 3.0x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Jun25
Promoters
Created with Highcharts 8.2.2Jun25
Others
Created with Highcharts 8.2.2Jun25
Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (12)
Followers (1)